Search results
Order by most recent / most popular / relevance
Results: 1-10 of 38
Indian Supreme Court rules Novartis cancer drug change not patentable
- Shook Hardy & Bacon LLP
- -
- India
- -
- April 4 2013
The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also
SCOTUS hears arguments on patentability of human genes
- Shook Hardy & Bacon LLP
- -
- USA
- -
- April 18 2013
The U.S. Supreme Court (SCOTUS) heard arguments on Monday specifically addressing whether "human genes are patentable." Ass'n for Molecular Pathology
Genetic technologies settles infringement suit over non-DNA coding technology
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 2 2013
Genetic Technologies Ltd. (GTG) has reportedly settled a patent infringement lawsuit filed in late 2012 against PreventionGenetics. While the terms
Court dismisses action to correct inventorship of two patents
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 19 2011
A federal court in Massachusetts has determined that genetic researchers could neither substitute themselves as the inventors of two patents nor correct the patents' inventorship to add their names under 35 U.S.C. 256, because they had not engaged in any collaborative efforts with the named inventors
Drug companies and policymakers watch patent dispute before India’s high court
- Shook Hardy & Bacon LLP
- -
- India
- -
- March 15 2012
According to a news source, the India Supreme Court will hear final arguments in March 2012 on whether the manufacturer of a drug that could not be patented in India because it was created before 1995 during a moratorium on the grant of patents to Western companies, may obtain a patent in that country for a newer form of the drug
Eleventh Circuit turns aside FTC challenge to pay-for-delay deal
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 3 2012
The Eleventh Circuit Court of Appeals has dismissed an antitrust action filed by the Federal Trade Commission (FTC) against a name-brand prescription drug manufacturer (the patent holder) and generic drug companies that entered into pay-for-delay agreements to settle patent infringement claims filed against the generic drug companies
Federal Circuit’s patent infringement ruling conflicts with USPTO re-examination on validity
- Shook Hardy & Bacon LLP
- -
- USA
- -
- November 1 2012
The Federal Circuit Court of Appeals has denied a request for an en banc rehearing by a medical-device patent holder which argued that the U.S. Patent and Trademark Office’s (USPTO’s) Board of Patent Appeals had effectively nullified a previous Federal Circuit decision on the validity of its patent
Biotech company settles claims that counsel divulged confidential information
- Shook Hardy & Bacon LLP
- -
- USA
- -
- April 21 2011
A federal court in California has dismissed with prejudice claims that a biotech company filed against its former counsel alleging that the law firm had provided confidential information about the company's patent applications to another client
Federal Ccircuit panel returns to Gore-Tex graft dispute, clarifies willfulness standard for enhanced damages
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 21 2012
The Federal Circuit Court of Appeals has vacated parts of its February 2012 decision in a long-running patent dispute over a prosthetic vascular graft and remanded the matter for the district court to address the objective prong of the willfulness standard and reconsider its denial of W.L. Gore’s motion for judgment as a matter of law of no willful infringement. Bard Peripheral Vascular, Inc. v. W.L. Gore & Assoc., Inc., No. 2010-1510 (Fed. Cir., decided June 14, 2012
EU Court of Justice nixes patents for stem-cell inventions involving human embryo destruction
- Shook Hardy & Bacon LLP
- -
- European Union
- -
- October 20 2011
The European Union (EU) Court of Justice has determined that EU patent law does not protect neural precursor cells and the processes for their production from embryonic stem cells
Current Search
- Workarea - Patents
- Workarea - Healthcare
- Workarea - Litigation
- Author - Madeleine McDonough